The Liver Meeting 2023-2023 TLM Debrief Session (MASLD Debrief)

Video Transcription

Video Summary

The video transcript summarizes the MASL 2023 conference, highlighting new nomenclature changes to MASLD and MASH. Key topics covered include studies on pathophysiology, epidemiology, diagnostics, machine learning, and therapeutics for non-alcoholic fatty liver disease. Studies on genetic variants, imaging, blood tests, and liver transplantation outcomes were discussed. Promising results were seen in trials for statins, SGLT2 inhibitors, bariatric surgery, novel medications, and combination therapies for advanced fibrosis and cirrhosis. The importance of non-invasive testing, precision medicine, and future conferences were emphasized. Attendees were encouraged to attend upcoming conferences in Las Vegas and DDW, with plans for TLM 2024 in San Diego. The conference was deemed successful and attendees were thanked for their participation.

Asset Caption

Mazen Noureddin, MD, MHSc: MASLD Debrief

Keywords

MASL 2023 conference

nomenclature changes

MASLD

MASH

non-alcoholic fatty liver disease

therapeutics

precision medicine